cantx home


The CanTx Science

This exciting new joint venture unites cutting-edge technology from industry with that from world-class academia.

NOVOGEN has developed super-benzopyran (SBP) drugs designed to kill chemo-resistant cancer stem cells.

YALE has uniquely identified and isolated the ovarian cancer stem cells that are responsible for tumor formation, heterogeneity, chemo-resistance and recurrence.

This union has produced Cantrixil®, a product designed to be administered intra-peritoneally to patients with cancers confined to the abdominal cavity, starting with patients with ovarian cancer.

The CanTx collaboration has already confirmed that the Novogen SBP’s can uniquely kill these ovarian cancer stem cells.